HAGEN BRETT R (Chief Accounting Officer) sold 1.2% of their position (36.00 shares) of KALARIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $342.28 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/27/2025ACC: 0000950170-25-009204
Officer· Chief Accounting Officer
Since Jul 2020
-36.00
Net shares
Net seller
$342.28
Total sold
2
Open market trades
0B · 2S
2
Total transactions
36.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−32.00
Price / share
$9.45
Trade value
$302.52
% of position
1.1%
1/23/2025
2.96K→2.93K
Common Stock
Direct
Shares
−4.00
Price / share
$9.94
Trade value
$39.76
% of position
0.1%
1/23/2025
2.93K→2.93K
Total
Net shares
−36.00
Net value
-$342.28
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2025 | S · Sale | −32.00 | $9.45 | $302.52 | 1.1% | 2.96K | 2.93K |
| Common Stock Direct | 1/23/2025 | S · Sale | −4.00 | $9.94 | $39.76 | 0.1% | 2.93K | 2.93K |
| Total | −36.00 | -$342.28 | ||||||
Derivative Transactions0
No derivative transactions reported